SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression-Reference-Cited by-同舟云学术

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

Published:2011-02 Issue:7333 Volume:470 Page:269-273
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Ding Zhihu,Wu Chang-Jiun,Chu Gerald C.,Xiao Yonghong,Ho Dennis,Zhang Jingfang,Perry Samuel R.,Labrot Emma S.,Wu Xiaoqiu,Lis Rosina,Hoshida Yujin,Hiller David,Hu Baoli,Jiang Shan,Zheng Hongwu,Stegh Alexander H.,Scott Kenneth L.,Signoretti Sabina,Bardeesy Nabeel,Wang Y. Alan,Hill David E.,Golub Todd R.,Stampfer Meir J.,Wong Wing H.,Loda Massimo,Mucci Lorelei,Chin Lynda,DePinho Ronald A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09677.pdf

Reference33 articles.

1. Andreoiu, M. & Cheng, L. Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum. Pathol. 41, 781–793 (2010)

2. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. (2010)

3. Walsh, P. C., DeWeese, T. L. & Eisenberger, M. A. Localized prostate cancer. N. Engl. J. Med. 357, 2696–2705 (2007)

4. Rubin, M. A. Targeted therapy of cancer: new roles for pathologists—prostate cancer. Mod. Pathol. 21 (Suppl 2). S44–S55 (2008)

5. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11–22 (2010)

Cited by 443 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers;Non-coding RNA Research;2024-12

2. Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer;Cancer Biology & Therapy;2024-08-20

3. Hippo signaling modulation and its biological implications in urological malignancies;Molecular Aspects of Medicine;2024-08

4. Diverse landscape of genetically engineered mouse models: Genomic and molecular insights into prostate cancer;Cancer Letters;2024-07

5. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression;Molecular Cancer;2024-05-29